Abstract
The use of oral corticosteroids and reduced weight bearing in Duchenne muscular dystrophy (DMD) increases risk of poor bone health, resulting in osteoporosis, bone pain, fractures and vertebral deformities. We carried out a retrospective study within Birmingham Heartlands Hospital's Paediatrics Department, one of our largest referral centres for Neuromuscular
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
